Clofoctol is a bacteriostatic antibiotic used primarily in the treatment of respiratory tract infections and for the prevention of post-surgical infections following ear, nose, and throat procedures. As… Read more
Clofoctol is a bacteriostatic antibiotic used primarily in the treatment of respiratory tract infections and for the prevention of post-surgical infections following ear, nose, and throat procedures. As a synthetic antibacterial agent, it is valued for its ability to target bacterial protein synthesis. To support rigorous analytical research and regulatory compliance, pharmaceutical laboratories require high-quality reference standards of Clofoctol API. This category includes these essential reference materials, along with pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These products are vital for accurate impurity profiling, method validation, and ongoing quality control, ensuring that analytical assays can reliably detect and quantify the drug and its related substances throughout the development and manufacturing process.